Virtual Medicinal Product (VMP) - Pembrolizumab 150mg/100ml in Sodium chloride 0.9% infusion bags
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Pembrolizumab 150mg/100ml in Sodium chloride 0.9% infusion bags | Start Date 12-11-2024 | End Date |
| Abbreviated Name | Abbreviated Name Pembrolizumab 150mg/100ml in Sodium chloride 0.9% inf bags | Start Date 12-11-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 100.0
- UDFS UOM
- ml
- Unit Dose UOM
- bag
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01FF02
- BNF Codes
-
- BNF code 08010500
| Code | Start Date | End Date |
|---|---|---|
| 44062511000001103 | 12-11-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Pembrolizumab | Based on Ingredient Substance | 1.5 mg | 1 ml |
Name
Pembrolizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.5
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMPembrolizumab
-
VMP(Current) Pembrolizumab 150mg/100ml in Sodium ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 bag |